Related Experiment Video
Updated: Feb 16, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or
Kathleen M Fox1, Ming-Hui Tai2, Karel Kostev3
1Strategic Healthcare Solutions LLC, Aiken, SC, USA.
Insights
Most patients with atherosclerotic cardiovascular disease (ASCVD) on statins do not reach their LDL-C goal of <70 mg/dL. Despite this, treatment regimens rarely change in routine care.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- European guidelines recommend a low-density lipoprotein cholesterol (LDL-C) goal of <70 mg/dL for patients with atherosclerotic cardiovascular disease (ASCVD).
- Previous studies indicate low rates of achieving LDL-C goals in real-world settings.
- Statin utilization and its impact on goal attainment require further investigation in routine care.
Purpose of the Study:
- To assess LDL-C goal attainment (<70 mg/dL) in ASCVD patients using moderate- or high-intensity statins.
- To describe LDL-C goal attainment across different statin utilization patterns in routine care.
- To analyze treatment pattern changes in relation to LDL-C goal attainment.
Main Methods:
- Retrospective cohort study using electronic medical records from QuintilesIMS® Disease Analyzer in Germany.
- Identified ASCVD patients on moderate- or high-intensity statins between 2012-2014.
- Assessed LDL-C goal attainment using the lowest LDL-C value and analyzed treatment patterns (no change, switch, titration, discontinuation) over at least one year of follow-up.
Main Results:
- In over 14,000 patients annually (mean age 71, 35% female), approximately 80% had LDL-C ≥70 mg/dL.
- Only 11-24% of patients achieved LDL-C goal attainment, varying by treatment pattern.
- Despite low goal attainment, most patients (79-81%) had no change in statin regimen; 14-16% discontinued statins.
Conclusions:
- A majority of ASCVD patients on moderate- or high-intensity statins do not achieve the recommended LDL-C goal of <70 mg/dL.
- Treatment regimens for ASCVD patients are infrequently modified, even when LDL-C goals are not met.
- This highlights a potential gap in optimizing lipid-lowering therapy in routine clinical practice.
Background:
European clinical guidelines recommend a low-density lipoprotein cholesterol (LDL-C) goal of < 70 mg/dL. Statin use varies and past studies suggest low rates of real-world goal attainment. This study describes LDL-C goal attainment among atherosclerotic CV disease (ASCVD) patients with various utilization patterns of moderate- or high-intensity statins in routine care.
Methods:
This retrospective cohort study used electronic medical records data from the QuintilesIMS® Disease Analyzer (> 2 million individuals annually) to identify ASCVD (coronary atherosclerosis, stable/unstable angina, myocardial infarction, ischemic stroke, transient ischemic attack, aneurysm, peripheral artery disease) patients on moderate-/high-intensity statin in Germany. Proportion of patients with LDL-C < 70 mg/dL was determined using the lowest LDL-C value for each patient (index) in 2012, 2013, and 2014, while on statin. Treatment patterns were assessed for patients with at least 1 year of post-index follow-up. Results were stratified by year and treatment pattern [no change, switch, dose up-/down-titration, discontinuation (≥ 90 day gap)].
Results:
In > 14,000 patients assessed in each year (mean age 71 years, 35% female, 8-12% taking high-intensity statins), approximately 80% had LDL-C ≥ 70 mg/dL. Treatment patterns were assessed for most (88-93%) patients. Approximately 79-81% of patients made no change to statin regimens, 1% switched statins, 14-16% discontinued; 1% of moderate-intensity patients up-titrated, and 3% of all patients down-titrated. LDL-C goal attainment in these treatment pattern groups was 20, 16-24, 17, 11-14, and 17-19%, respectively.
Conclusions:
Majority of ASCVD patients had LDL-C ≥ 70 mg/dL while on moderate-/high-intensity statins. Despite low LDL-C goal attainment, few patients changed their treatment regimens.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Receptor-mediated Endocytosis
Cholesterol: Significance and Regulation
Considering cholesterol and...
Receiver Operating Characteristic Plot
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Sound Intensity

